Ob/Gyn Medical News about ovarian carcinoma

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Is the current concept of recurrent ovarian carcinoma as a chronic disease also applicable in platinum resistant patients
Archives of Gynecology and Obstetrics, 07/01/09

Guth U et al. - There is not only the known dichotomy between platinum sensitive and resistant ROC patients, but rather also within the platinum resistant subgroup itself. There is a considerably large subgroup of platinum resistant patients who will subsequently enter a phase where multiple treatment programs will be considered and administered. These patients have similar survival rates compared to those from the platinum sensitive patient group and the therapy principles of a chronic disease are applicable.

<< Previous
The unbooked mother: a cohort study of maternal and foetal...

Next >>
Establishing construct validity of a virtual-reality training...

Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09 Relevance Score: 69%

Serous papillary peritoneal carcinoma: Unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review
Critical Reviews in Oncology/Hematology, 11/12/09 Relevance Score: 67%

Precursors of endometrial and ovarian carcinoma
Virchows Archiv, 11/02/09 Relevance Score: 67%

Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology
Diagnostic Cytopathology, 10/28/09 Relevance Score: 67%

XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma
European Journal of Obstetrics & Gynecology and Reproductive Biology, 10/09/09 Relevance Score: 67%